| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |